Clinical Trial Update: Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing safety and preliminary efficacy of an allogeneic adoptive immune therapy in advanced AIDS patients; the study is reported as completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Allogeneic adoptive immune therapy

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Human Immunodeficiency Virus, Immunodeficiency | Phase 1, Phase 2 | Status: COMPLETED